Massachusetts Jobs

MassHire JobQuest Logo

Job Information

Rhythm Pharmaceuticals Senior Medical Communications Writer in Boston, Massachusetts

Company Overview

Rhythm is a global, commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with rare neuroendocrine diseases. We develop medicines for previously untreatable or undertreated diseases and provide meaningful support for healthcare providers and patients and their families. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to adapt, learn, and our tenacity to overcome barriers, together.

Opportunity Overview

As a Senior Medical Communications Writer, you will be responsible for researching, writing, and editing publications based on Rhythm’s R&D and therapeutic areas. This position will also provide medical writing support for associated materials to the Global Medical Affairs Medical Communications and Information functions .

Responsibilities and Duties

  • Perform literature reviews and solicit input from medical, statistical and operational resources as necessary to support data analysis and document content.

  • Assist with review of data to ensure cleanliness/appropriateness for analysis, hypothesis testing, QA of statistical output, and data compilation to support data summaries/presentations.

  • Writing scientific publications (papers for peer-reviewed medical journals, abstracts, posters, and slide presentations.

  • Other writing responsibilities include internal educational scientific slide kits, conference reports, and field medical training materials.

    Qualifications and Skills

  • Proven medical writing skills (particularly experience with developing scientific peer reviewed publications)

  • Expert knowledge of document content preparation, including the use of style guides, medical dictionaries, and online medical writing resources.

  • Edits to achieve consistency with scientific communication platform, uses precise accurate language and grammar and has a high attention to detail.

  • Ability to interpret and summarize complex tabular and graphical data sets.

  • Comfortable working with co-authors (both external and internal), with the ability to collaborate in a matrixed environment using exceptional written and verbal communication skills. Independently resolves document content issues and addresses questions by resolving discrepancies.

  • Strong organizational skills (Advanced project management and organizational skills). Ability to work independently, prioritize, and multitask to meet timelines under changing conditions.

  • Strong analytical mind with the proven ability to analyze, interpret, and summarize complex data.

  • Advanced understanding of drug development, clinical research, study designs, biostatistics, pharmacology, and medical terminology.

  • Advanced degree (RN, PA, MS, MPH, PhD, or PharmD) or equivalent in a scientific or health care field required.

  • Medical writing experience authoring scientific publication and presentations.

  • Preferred 3-5 years medical communication/publication writing experience.

  • Experience in obesity or rare diseases preferable.

  • CMPP certification preferred.

    This role is based out of our corporate office in Boston, Massachusetts. Rhythm operates in a hybrid-work model. Candidates applying must be willing and able to be in the Boston office in coordination with their department and business needs. This role may involve some travel.

    More about Rhythm

    Our lead asset, IMCIVREE® (setmelanotide), is a precision medicine designed to treat hyperphagia, an insatiable, pathological hunger characterized by abnormal food-seeking behaviors, and early- or rapid-onset severe obesity caused by an impairment of a pathway in the hypothalamus called the melanocortin-4 receptor (MC4R) pathway. IMCIVREE® is the first and only approved therapy for certain rare MC4R pathway diseases in the United States, Europe, Great Britain and several other countries. In collaboration with leading experts across the world, Rhythm is advancing the most comprehensive clinical research program ever initiated in MC4R pathway diseases, including a Phase 3 trial for acquired hypothalamic obesity. In addition, we are leveraging our extensive genetic database, global network of researchers, a track record of regulatory successes and global commercial infrastructure to develop a full portfolio of treatment options to patients struggling with hyperphagia and severe obesity and ensuring they get the treatment that is right for them.

    We continue to advance care and precision medicines that address rare diseases. We are focused on expanding access to IMCIVREE® to reach more patients and developing novel therapies for other rare neuroendocrine diseases, including congenital hyperinsulinism. Rhythm’s headquarters is in Boston, MA.  


Powered by JazzHR